BMY vs PRVA · P/E 17, rev $24.46B vs P/E 135, rev $1.24B
Bristol-Myers Squibb Company (BMY) versus Privia Health Group Inc (PRVA) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Privia Health Group Inc (PRVA) is a health information services company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported PRVA revenue for 2026-06-30 was $1.24B. Net income was $12.1M. PRVA currently screens at market cap $2.90B and trailing P/E 135.4.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. PRVA currently screens at market cap $2.90B and trailing P/E 135.4.
Not investment advice. Open the BMY and PRVA stock pages for the full models.
Not investment advice.